Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-06-18

Clinical Trial Update: Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

A randomized Phase 2 trial in metastatic renal cell carcinoma comparing pre-chemotherapy Leukine versus Leukine with dexamethasone, in combination with gemcitab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-FU (5-fluorouracil)
  • DEXAMETHASONE (Dexamethasone)
  • Gemzar (gemcitabine)
  • Leukine (sargramostim)

Snippet

Sponsor: University of Kentucky | Conditions: Renal Cell Carcinoma | Phase 2 | Status: WITHDRAWN